Vaccination recommendations are based, whenever possible, on the results of current scientific studies and established immunologic principles. Therefore, not all recommendations will be consistent with guidance provided in the context of manufacturers' data sheets.
This update of the WSAVA Vaccination Guidelines includes modified recommendations on the initial vaccination schedule for young dogs and cats, revaccination (booster) schedules, vaccine adverse events, new, regionally available vaccines, as well as updates on recommended protocols for shelter-housed dogs and cats.
The guidelines also include new, important information on the role of serological testing for the purpose of assessing vaccineassociated immunity among individual patients. With improved point-of-care testing technology, as well as increasing concerns among pet owners over risks associated with excessive vaccination, the opportunity to monitor antibody responses to vaccination at the time of appointment represents a relevant application for clinical practice.
The reader is reminded, however, that vaccination guidelines are merely recommendations, not requirements. With the exception of rabies vaccination (where required by law), veterinarians have considerable discretion in the selection and use of vaccines in companion animal practice. Published vaccination guidelines have become a credible resource for the veterinary profession in sustaining rational vaccination protocols in an ever-changing vaccine market. Although veterinarians are not obligated to adhere to all of the recommendations outlined, a review of this iteration of the WSAVA Vaccination Guidelines should not be optional.
